Glow Completes Successful Pilot Production of Proprietary MyCell® Liquid Cannabis Ingredients and Adds Multiple New Cannabinoids to Portfolio
News
28 . 06 . 2023
21 . 03 . 2023
Glow Launches New Brand Identity to Underscore its High-Performance, Technology-Driven Portfolio of Natural Ingredients
08 . 11 . 2022
Glow Lifetech Completes Development of Proprietary MyCell® Liquid Cannabis Ingredients; Advances Plans to Launch In Canadian Market
18 . 07 . 2022
Glow Lifetech Reports Positive Preliminary Results from Clinical Study of Artemic Support® on Patients with Long COVID Syndrome
14 . 07 . 2022
Glow Announces Extension of Warrant Expiry
07 . 07 . 2022
Glow Provides Update on Cannabis Development Activities and Ongoing Clinical Studies
11 . 01 . 2022
Glow Completes Reactor Commissioning and Initiates Development of Proprietary MyCell® Water-Soluble Cannabis Ingredients
29 . 12 . 2021
Glow Appoints Scientific & Regulatory Expert Advisors to Advance Commercial Activities